Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

93.86 -2.59 (-2.69%)
Official Closing Price Updated: 4:15 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
28 29 30 31 32 33 34 35 Next >
Could Bionano Genomics Be a Millionaire-Maker Stock?
This provider of genome mapping tools is showing signs of exponential growth ahead. 
Via The Motley Fool
Illumina To Webcast Upcoming Investor Conference
From Illumina, Inc.
Via Business Wire
PCR- and NGS-Based Diagnostic Testing Market Revenue to Cross USD 26.5 Bn by 2027: Global Market Insights Inc.
Major PCR- and NGS-based diagnostic testing market players include Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Eppendorf AG; Fluotics; Hamilton Company; Illumina, Inc.; Integra LifeScience... 
Via Newswire.com
Topics Death
Illumina Celebrates AAPI Heritage Month
SOURCE: Illumina 
Via 3BL Media
Unlocking the Covid Code
SOURCE: Illumina 
Via 3BL Media
Topics Earnings
San Diego Squared Is Empowering Tomorrow's STEM Leaders Today
SOURCE: Illumina 
Via 3BL Media
Bringing Bright Minds Together at SPARK
SOURCE: Illumina 
Via 3BL Media
Kansas City Lights the Night with a New Research Institute
SOURCE: Illumina 
Via 3BL Media
Illumina Celebrates International Biodiversity Day
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change
Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development
From Illumina, Inc.
Via Business Wire
These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know
Former high-flyers Dexcom and Tandem Diabetes are among seven health care stocks breaking down right now, according to MarketSmith.com. 
Via Investor's Business Daily
Immuno Oncology Assays Market Worth $7.9 Billion by 2026 - Exclusive Report by MarketsandMarkets™
The global immuno-oncology assays market is projected to reach $7.9 billion by 2026. Cancer cell-based assays market report provides crucial industry insights that will help your business grow. 
Via SBWire
Tumor Genomics Market Share, Industry Growth, Trend, Statistics, Drivers, Demand, Key Companies by 2028
Increasing number of cancer cases, rising government initiatives and projects, new drug developments, and increasing demand for cancer-specific diagnostics are factors driving global tumor genomic... 
Via SBWire
Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative
SOURCE: Illumina 
Via 3BL Media
DNA Sequencing in Drug Discovery Market Worth Observing Growth: Sigma-Aldrich, Siemens Healthcare Diagnostics, Promega
The DNA Sequencing In Drug Discovery Market research study presents insights into the changing competitive landscape and offers clients an accurate picture of the future direction of this industry. (To... 
Via SBWire
Topics Regulatory Compliance
Tesla, Nio Significantly Cut From Baillie Gifford Portfolio, Here's What The Firm Bought Instead In Q1
Investment management firm Baillie Gifford shed significant stake in electric carmakers Tesla Inc (NASDAQ: 
Via Benzinga
Forensic Equipment and Supplies Market Trends, Analysis, Demand and Global Industry Research Report, Region, and Segment Forecasts, 2021-2028
The growing significance of DNA analysis in criminal investigations and the rising number of forensic laboratories are the key factors fueling the growth of this market 
Via SBWire
Topics Supply Chain
Next-Generation Sequencing (NGS) Market Worth $24.2 Billion by 2026 - Exclusive Report by MarketsandMarkets™
The next-generation sequencing market is projected to reach $24.2 billion by 2026. NGS market report provides crucial industry insights that will help your business grow. 
Via SBWire
Is Illumina Sandbagging With Its Full-Year Guidance?
It just might be. 
Via The Motley Fool
HLA Typing for Transplant Market Size USD 1,206.02 Million by 2028 Says a New Research Report by Reports and Data
HLA matching boosts development of new healthy blood cells and reduces the chances of graft-versus-host disease. 
Via SBWire
2 of the Best Healthcare Stocks You'll Find Today
The advice of Warren Buffett's biggest influencers supports these solid picks. 
Via The Motley Fool
Stock Market Rally Navigates Earnings From Apple, Tesla, Google, Facebook, Microsoft, Amazon
The stock market rally navigated earnings from Apple, Tesla and the other "big six" market cap companies. Many breakouts, but not all succeeded. 
Via Investor's Business Daily
Illumina To Webcast Upcoming Investor Conference
From Illumina, Inc.
Via Business Wire
Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition
From Illumina, Inc.
Via Business Wire
Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative
From Illumina, Inc.
Via Business Wire
Time100 Most Influential Companies: What 61 Publicly Traded Companies Are On The Inaugural List?
Time Magazine is well-known for its annual Time100 Most Influential People issue. The media brand unveiled a new annual list called the TIME100 Most Influential Companies. ... 
Via Benzinga
How Illumina's Q1 Results Delighted Investors
Nearly everything went right for the genomic sequencing pioneer. 
Via The Motley Fool
Illumina Inc (ILMN) Q1 2021 Earnings Call Transcript
ILMN earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Illumina: Q1 Earnings Insights
Shares of Illumina (NASDAQ:ILMN) rise in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 15.24% year over year to $1.89,... 
Via Benzinga
Illumina Stock Dips Despite First-Quarter Beat, Strong Earnings Guide
Illumina stock skidded on Tuesday after the medical technology giant reported adjusted income of $1.89 per share on $1.09 billion in sales. 
Via Investor's Business Daily
< Previous 1 2
...
28 29 30 31 32 33 34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.